Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report

Successful treatment with afatinib following the failure of osimertinib rechallenge with osimertinib-induced interstitial lung disease: A case report

Herein, we report the case of an 84-year-old woman with epidermal growth factor receptor (EGFR) mutation exon 19 deletion postoperative recurrent lung adenocarcinoma. Osimertinib was administered as a first-line treatment; however, she was urgently admitted to our hospital due to dyspnea on the 46th...

Full description

Bibliographic Details
Main Authors: Yozo Sato, Akimasa Sekine, Eri Hagiwara, Midori Sato, Takafumi Yamaya, Masato Asaoka, Katsuyuki Higa, Satoshi Ikeda, Tomohisa Baba, Shigeru Komatsu, Tae Iwasawa, Takashi Ogura
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Osimertinib
Afatinib
Drug-induced interstitial lung disease (ILD)
Lung adenocarcinoma
EGFR
Online Access:http://www.sciencedirect.com/science/article/pii/S221300712100112X

Internet

http://www.sciencedirect.com/science/article/pii/S221300712100112X

Similar Items